David M. Knott Jr’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$826K Sell
13,622
-8,378
-38% -$488K 0.49% 38
2025
Q4
$1.19M Sell
22,000
-5,000
-19% -$241K 0.55% 30
2025
Q3
$1.22M Hold
27,000
0.49% 31
2025
Q2
$1.25M Buy
27,000
+8,000
+42% +$393K 0.57% 29
2025
Q1
$1.16M Buy
+19,000
New +$1.11M 0.55% 27
2022
Q2
Sell
-42,409
Closed -$3.1M 189
2022
Q1
$3.1M Hold
42,409
0.99% 30
2021
Q4
$2.64M Buy
+42,409
New +$2.49M 0.9% 32

Other funds holding BMY

David M. Knott Jr's BMY Position: Q1 2026 in Review

David M. Knott Jr reduced its Bristol-Myers Squibb (BMY) stake by 38% in Q1 2026, selling an estimated $488K and leaving 13,622 shares worth $826K. The position accounts for 0.49% of the portfolio, ranked #38.

David M. Knott Jr first reported a position in BMY in Q4 2021 and has held it in 7 quarters since. The position peaked at $3.1M in Q1 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • David M. Knott Jr held 13,622 shares of Bristol-Myers Squibb worth $826K as of Q1 2026.
  • David M. Knott Jr sold 8,378 Bristol-Myers Squibb shares in Q1 2026, an estimated $488K.
  • Bristol-Myers Squibb made up 0.49% of David M. Knott Jr's portfolio in Q1 2026, its #38 holding.
  • David M. Knott Jr first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 7 quarters since.
  • David M. Knott Jr's Bristol-Myers Squibb position peaked at $3.1M in Q1 2022.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on David M. Knott Jr's 13F filing for Q1 2026, filed 14 May 2026.